Risk of neural tube defects higher for babies of women on HIV therapy with dolutegrav
Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other antiretroviral drugs. The ...
Jul 22, 2019